@probablyparched's period weight stall on GLP-1, explained

What did @probablyparched actually say?

Honestly? Not much that's medically analyzable. The transcript captured from this video is largely incoherent, appearing to be a transcription error or audio processing failure rather than a coherent health claim. What we do have is the caption, where the creator writes that their weight is at "a bit of a standoff" and attributes it to being on their period, adding "she's doing her thang" and expressing patience with the process. They're using semaglutide (tagged as compound GLP-1) alongside weightlifting as part of a weight loss journey.

So the actual claim being made, via caption rather than spoken word, is this: menstrual cycle water retention can stall the scale temporarily, and that's fine. That's a pretty reasonable thing to say, as it turns out.

Does the science back this up?

Yes, this part checks out. Menstrual cycle-related weight fluctuations are well-documented and can range from 1 to 5 pounds depending on the individual, driven primarily by hormonal shifts affecting fluid retention, not fat gain.

Research published by Bisdee et al. (1989, British Journal of Nutrition) documented cyclical weight changes across the menstrual cycle, with body weight peaking in the luteal phase due to fluid retention tied to progesterone and aldosterone activity. A more recent review by Gorczyca et al. (2016, European Journal of Nutrition) confirmed that both caloric intake and macronutrient cravings shift across cycle phases, which can compound apparent weight changes.

For someone on a GLP-1 receptor agonist like semaglutide, this matters because these medications suppress appetite significantly, but they don't override hormonal physiology. The scale can and does stall or temporarily increase during the luteal phase even when someone is fully adherent to their medication and diet. Clinicians who work in GLP-1 prescribing are aware of this, but it's rarely communicated clearly to patients.

What did they get wrong (or right)?

The creator actually got this right, and it's worth giving credit for that. Too many weight loss content creators on TikTok treat any scale increase as a crisis, leading followers to restrict further or second-guess their medication. The creator's response, patience and continued trust in the process, is the clinically appropriate one.

What's harder to evaluate is the compounded semaglutide angle. The hashtag "compound" suggests they're using a compounded GLP-1 product rather than brand-name Wegovy or Ozempic. Compounded semaglutide is not FDA-approved and is not equivalent to FDA-approved semaglutide formulations. The FDA has stated explicitly that compounded drugs are not tested for safety and efficacy in the same way. This doesn't mean compounded products don't work for some people, but it's a meaningful distinction that gets glossed over constantly in this content space.

The creator doesn't make any clinical claims about their compound product, so there's nothing to reject here. But the audience watching a video tagged with both "compound" and "semaglutide" is likely drawing their own conclusions.

What should you actually know?

If you're on a GLP-1 receptor agonist and your scale isn't moving for a week or two, your menstrual cycle is a legitimate variable worth tracking before you catastrophize. Apps like Clue or Apple Health allow cycle phase logging alongside weight, which can reveal patterns that would otherwise look like plateaus.

That said, actual weight loss plateaus on semaglutide do happen and are separate from hormonal fluctuations. Research by Wilding et al. (2021, New England Journal of Medicine) showed that weight loss with semaglutide tends to plateau around 60-68 weeks, with some patients requiring clinical reassessment. If you're seeing consistent non-movement across multiple cycles, that's a conversation for your prescribing provider, not a reason to increase your dose on your own.

One more thing worth knowing: the combination of GLP-1 therapy and weightlifting, as this creator is doing, is actually well-supported. Resistance training helps preserve lean muscle mass during GLP-1-driven weight loss, which matters for long-term metabolic health. Preserve muscle, lose fat. That's the goal, and this creator seems to understand it.